ArticleLung Cancer (Auckland, N.Z.)2023

CheckMate-722: The Rise and Fall of Nivolumab with Chemotherapy in TKI-Refractory EGFR-Mutant NSCLC.

Alexandria T M Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.